BJU Int

1. ANG ZY, Kong YL, Md Nesran ZN, Lee SWH, et al
   Efficacy of decision aid delivery modes in prostate cancer screening: umbrella review and network meta-analysis.
   BJU Int. 2024 Oct 14. doi: 10.1111/bju.16545.
   

   >> Share

   
   

   
   BMC Urol

2. DAHAN J, Pinthus J, Delouya G, Taussky D, et al
   Investigation of association between clinically significant prostate cancer, obesity and platelet to-lymphocyte ratio and neutrophil -to-lymphocyte ratio.
   BMC Urol. 2024;24:226.
   

   >> Share

   
   

   
   Br J Cancer

3. SHEN M, Garcia-Marques F, Muruganantham A, Liu S, et al
   Identification of a 5-gene signature panel for the prediction of prostate cancer progression.
   Br J Cancer. 2024 Oct 14. doi: 10.1038/s41416-024-02854.
   

   >> Share

   
   

   
   Cancer

4. MOUSA A, Nguyen DD, Lalani AK, Satkunasivam R, et al
   Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen-deprivation therapy: A population-based assessment of adherence to therapeutic monitoring guidelines.
   Cancer. 2024 Oct 13. doi: 10.1002/cncr.35606.
   

   >> Share

   
   

   
   Endocrinology

5. VARSHNEY S, Shankar K, Kerr HL, Anderson LJ, et al
   The LEAP2 Response to Cancer-Related Anorexia-Cachexia Syndrome in Male Mice and Patients.
   Endocrinology. 2024;165:bqae132.
   

   >> Share

   
   

   
   Int J Radiat Oncol Biol Phys

6. FRANCOLINI G, Di Cataldo V, Garlatti P, Simontacchi G, et al
   Androgen Deprivation Therapy in Intermediate Prostate Cancer Treated With Radiation Therapy: The Wide Heterogeneity and Complexity of an Apparently Simple Situation.
   Int J Radiat Oncol Biol Phys. 2024;120:1008-1010.
   

   >> Share

   
   
7. SINGH M, Maitre P, Krishnan A, Adsul K, et al
   Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of Prostate.
   Int J Radiat Oncol Biol Phys. 2024;120:1011-1020.
   

   >> Share

   
   

   
   Int J Urol

8. SHIOTA M
   Editorial Comment to Loss of phosphatase and tensin homolog expression in castration-sensitive prostate cancer predicts outcomes in men after prostatectomy.
   Int J Urol. 2024 Oct 15. doi: 10.1111/iju.15607.
   

   >> Share

   
   

   
   J Urol

9. FILON M, O'Neil B
   Can We Be Less Active in Prostate Cancer Surveillance?
   J Urol. 2024 Oct 16:101097JU0000000000004277. doi: 10.1097/JU.0000000000004277.
   

   >> Share

   
   

   
   N Engl J Med

10. VAN AS N, Griffin C, Tree A, Patel J, et al
    Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.
    N Engl J Med. 2024;391:1413-1425.
    

    >> Share

    
    

    
    Nat Rev Urol

11. DEE EC, Todd R, Ng K, Aidoo-Micah G, et al
    Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards.
    Nat Rev Urol. 2024 Oct 18. doi: 10.1038/s41585-024-00948.
    

    >> Share

    
    

    
    Oncogene

12. LIN G, Tian F, Yu Q, Weng X, et al
    IL-17RA/CTSK axis mediates H. pylori-induced castration-resistant prostate cancer growth.
    Oncogene. 2024 Oct 18. doi: 10.1038/s41388-024-03169.
    

    >> Share

    
    

    
    PLoS One

13. MARSDEN T, Attard G, Punwani S, Giganti F, et al
    The RECONCILE study protocol: Exploiting image-based risk stratification in early prostate cancer to discriminate progressors from non-progressors (RECONCILE).
    PLoS One. 2024;19:e0295994.
    

    >> Share

    
    

    
    Prostate

14. YANAGISAWA T, Fukuokaya W, Hatakeyama S, Narita S, et al
    Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone-sensitive prostate cancer: A multicenter study.
    Prostate. 2024 Oct 17:e24813. doi: 10.1002/pros.24813.
    

    >> Share

    
    
15. SEMWAL H, Ladbury C, Sabbagh A, Mohamad O, et al
    Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer.
    Prostate. 2024 Oct 13. doi: 10.1002/pros.24793.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

16. YILMAZ EC, Harmon SA, Law YM, Huang EP, et al
    External Validation of a Previously Developed Deep Learning-based Prostate Lesion Detection Algorithm on Paired External and In-House Biparametric MRI Scans.
    Radiol Imaging Cancer. 2024;6:e240050.
    

    >> Share

    
    

    
    Urol Int

17. YU J, Zhou K, Wang J, Mao L, et al
    Preliminary efficacy, tolerability, and safety analysis of Darolutamide for metastatic castration?resistant prostate cancer: a single-center, open-label study.
    Urol Int. 2024 Oct 15:1-13. doi: 10.1159/000541929.
    

    >> Share

    
    

    
    Urology

18. CHECCUCCI E, Bauckneht M, Cisero E, Volpi G, et al
    PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience from a Multicenter Cohort.
    Urology. 2024 Oct 17:S0090-4295(24)00909-9. doi: 10.1016/j.urology.2024.
    

    >> Share

    
    
19. KRONSTEDT S, Chiu CB, Wahlstedt E, Cathey J, et al
    Should Military Veterans Be Classified as High Risk for Prostate Cancer Screening? A Systematic Review and Meta-analysis.
    Urology. 2024 Oct 17:S0090-4295(24)00908-7. doi: 10.1016/j.urology.2024.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share